Table 1 Characteristics of the cohort ( n = 130)
Characteristic | Mean ± SD |
|---|---|
Patient | |
Age at treatment (years) | 45.1 ± 5.5 |
BMI (kg/m2) (n = 95) | |
<25 | 52 (54.7) |
25 to 29 | 26 (27.4) |
≥30 | 17 (17.9) |
Race (n = 88) | |
Caucasian | 77 (87.5) |
Other | 11 (12.5) |
Smoking history (n = 123) | |
No | 82 (66.6) |
Yes | 41 (33.3) |
Gravidity (n = 129) | |
Nulligravid | 59 (45.7) |
Multigravid | 70 (54.3) |
Parity (n = 129) | |
Nulliparous | 70 (54.3) |
Multiparous | 59 (45.7) |
Menopausal status (n = 129) | |
Premenopausal | 110 (92.4) |
Perimenopausal | 8 (6.7) |
Postmenopausal | 1 (0.8) |
Prior fibroid treatment | |
None | 96 (73.8) |
Medical | 22 (16.9) |
Myomectomy | 2 (1.5) |
Endometrial ablation | 2 (1.5) |
MRgFUS | 8 (6.2) |
Symptom | |
Age at first diagnosis (years) (n = 104) | 41.5 ± 6.2 |
Duration of dominant symptom (months) (n = 98) | 20.6 ± 15.7 |
Presenting symptoms (n = 124) | |
Bleeding + Bulk | 39 (31.0) |
Bleeding only | 32 (25.4) |
Bulk only | 35 (27.8) |
Pain (±Bleeding or Bulk) | 20 (15.9) |
Baseline symptom severity score (n = 66) | 59.1 ± 18.0 |
Fibroid | |
Fibroid load (cm3) | 350 ± 307 |
Volume dominant fibroid (cm3) | 305 ± 292 |
Number of fibroids | |
1 | 50 (38.5) |
2 or 3 | 39 (30.0) |
>3 | 41 (31.5) |
Fibroid location | |
Submucosal intramural | 14 (10.8) |
Intramural | 86 (66.2) |
Subserosal | 22 (16.9) |
Transmurala | 8 (6.2) |
T2 signal intensity dark, minimal heterogeneity | 71 (54.6) |
Minimal heterogeneity | |
Minimal heterogeneity | 71 (54.6) |
Substantial heterogeneity | 44 (33.8) |
Isointense | 6 (4.6) |
Bright | 9 (6.9) |